CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahajan, R.
Right arrow Articles by Chari, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahajan, R.
Right arrow Articles by Chari, P.
Canadian Journal of Anesthesia 51:702-706 (2004)
© Canadian Anesthesiologists' Society, 2004

Obstetrical and Pediatric Anesthesia

Caudal neostigmine with bupivacaine produces a dose-independent analgesic effect in children

[L’administration caudale de néostigmine avec bupivacaïne produit une analgésie non reliée à la dose]

Rajesh Mahajan, MD, Vinod K. Grover, MD MNAMS and Pramila Chari, MD FAMS

From the Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Address correspondence to: Dr. Vinod K. Grover, H.No.53, Sector 24-A, Chandigarh-160023, India. Phone: 91-172-272-4220; Fax: 91-172-274-4401; E-mail: suman_vinod{at}yahoo.co.in

Purpose: To evaluate the analgesic efficacy and duration of varying doses of caudal neostigmine with plain bupivacaine and its side effects in children undergoing genito-urinary surgery.

Methods: In a randomized double-blind prospective study 80 boys aged two to eight years scheduled for surgical repair of hypospadias were allocated randomly to one of four groups (n = 20 each) and received either only caudal 0.25% plain bupivacaine 0.5 mL·kg–1 (Group I) or 0.25% plain bupivacaine 0.5 mL·kg–1 with neostigmine (Groups II–IV) in doses of 2, 3 and 4 µg·kg–1 respectively. Postoperative pain was assessed for 24 hr using an objective pain score. Blood pressure, heart rate, oxygen saturation, total amount of analgesic consumed and adverse effects were also recorded.

Results: The duration of postoperative analgesia in Group I (5.1 ± 2.3 hr) was significantly shorter than in the other three groups (II –16.6 ± 4.9 hr; III – 17.2 ± 5.5 hr; IV – 17.0 ± 5.8 hr; P < 0.05). Total analgesic (paracetamol) consumption was significantly more in Group I (697.6 ± 240.7 mg) than in the groups receiving caudal neostigmine (II – 248.0 ± 178.4; III – 270.2 ± 180.8 and IV –230.6 ± 166.9 mg; P < 0.05). Groups II, III and IV were comparable with regards to duration of postoperative analgesia and total analgesic consumption (P > 0.05). Incidence of nausea and vomiting were comparable in all four groups. No significant alteration in vital signs or any other adverse effects were observed.

Conclusions: Caudal neostigmine (2, 3 and 4 µg·kg–1) with bupivacaine produces a dose-independent analgesic effect ({approx}16–17 hr) in children as compared to those receiving caudal bupivacaine alone (approximately five hours) and a reduction in postoperative rescue analgesic consumption without increasing the incidence of adverse effects.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
N. Almenrader, M. Passariello, R. Mahajan, Y.K. Batra, S. Kumar, and P.A. Lonnqvist
Adjuncts to caudal blockade in children.
Br. J. Anaesth., March 1, 2006; 96(3): 401 - 402.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Canadian Anesthesiologists' Society.